Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis and Forecast to 2031: By Technology (Quantitative and Digital), Application (Clinical, Research, Forensic and Others), Product (Clinical, Research, Forensic and Others), and Region

Polymerase chain reaction (PCR) is a method used to amplify a specific region of DNA. The DNA is first denatured into single strands, and then primers have added that bind to the target region. The DNA is then amplified using a thermostable DNA polymerase. PCR can be used to amplify a specific region of DNA, or it can be used to generate large quantities of a specific DNA sequence.

Key Trends

Digital PCR (dPCR) and Real-time PCR (qPCR) technology are two of the most popular methods for PCR. dPCR is a newer technology that is becoming increasingly popular due to its higher accuracy and precision. qPCR is still the most widely used method due to its ease of use and lower cost.

Some of the key trends in dPCR and qPCR technology include:

– Increased accuracy and precision: dPCR is more accurate and precise than qPCR, making it the preferred method for many applications.

– Increased sensitivity: dPCR is more sensitive than qPCR, making it ideal for applications where low levels of target DNA need to be detected.

– Increased speed: dPCR is faster than qPCR, making it ideal for applications where speed is of the utmost importance.

Key Drivers

Digital PCR (dPCR) and Real-time PCR (qPCR) are two of the most popular methods for PCR-based detection of nucleic acids. Both methods are highly sensitive and specific, and can be used for a variety of applications including gene expression analysis, pathogen detection, and genotyping.

dPCR is typically more sensitive than qPCR, due to the fact that dPCR can quantify absolute copy numbers of target sequences, while qPCR can only relative copy numbers. In addition, dPCR is not affected by PCR inhibitors, while qPCR can be.

qPCR is typically faster and easier to set up than dPCR, and does not require specialized equipment. qPCR can also be used for multiplexing, while dPCR is typically limited to single plex assays.

Restraints & Challenges

There are several key restraints and challenges in the Digital PCR (dPCR) and Real-time PCR (qPCR) market. One of the key restraints is the high cost of these technologies. The high cost of dPCR and qPCR instruments and reagents is a major barrier to the widespread adoption of these technologies. Another key restraint is the lack of standardization in these technologies. There is no standardization in the protocols and methods used for dPCR and qPCR, which makes it difficult to compare results across different studies. Additionally, the lack of trained personnel is another challenge in the adoption of these technologies. There is a lack of trained personnel who are familiar with the use of these technologies, which limits the widespread adoption of these technologies.

Market segmentation

The Digital PCR (dPCR) and Real-time PCR (qPCR) market is segmented by technology, application, and product. By technology, the market is classified into quantitative and digital. By application, the market is divided into clinical, research, forensic and others. By product, the market is segmented into consumables & reagents, instrument, software & services. Region-wise, the market is segmented into North America, Europe, Asia-Pacific and rest of the world.

Key Players

The Key Players in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market market are, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, BioMerieux SA, Danaher Corporation, and Eppendorf.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Outlook
3.1. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market
4.3. Economic Impact Analysis

Chapter 5. Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Technology
5.1. Market Overview
5.2. Quantitative
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Digital
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application
6.1. Market Overview
6.2. Clinical
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Research
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Forensic and Others
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product
7.1. Market Overview
7.2. Consumable and Reagents
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Instruments
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Software and Services
7.4.1. Market Size and Forecast, 2021-2031 ($Million)
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Digital PCR (dPCR) and Real-time PCR (qPCR) Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.3. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.4. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.5. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.6.2. The U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.6.3. The U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.2.7. Canada
8.2.7.1. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.7.2. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.7.3. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.2.8. Mexico
8.2.8.1. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.2.8.2. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.2.8.3. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.3. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.4. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.5. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.6.2. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.6.3. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.3.7. France
8.3.7.1. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.7.2. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.7.3. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.3.8. U.K.
8.3.8.1. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.8.2. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.8.3. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.3.9. Spain
8.3.9.1. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.9.2. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.9.3. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.10.2. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.10.3. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.4. Asia-Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.5. Asia-Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.6.2. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.6.3. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.4.7. India
8.4.7.1. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.7.2. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.7.3. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.4.8. Japan
8.4.8.1. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.8.2. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.8.3. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.9.2. South Korea Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.9.3. South Korea Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.3. Rest of the World Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.4. Rest of the World Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.5. Rest of the World Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.6.2. Latin America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.6.3. Latin America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.7.2. Middle East Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.7.3. Middle East Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

8.5.8. Africa
8.5.8.1. Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.8.2. Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.8.3. Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.9. Rest of LAMEA
8.5.9.1. Rest of LAMEA Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Technology, 2021-2031, ($Million)
8.5.9.2. Rest of LAMEA Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Application, 2021-2031, ($Million)
8.5.9.3. Rest of LAMEA Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size and Forecast by Product, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Application Development
9.3.2. Application Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Bio-Rad Laboratories Inc.
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. F. Hoffmann-La Roche, Ltd.
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Abbott Laboratories
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Agilent Technologies
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Analytik Jena AG
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Becton Dickson and Company
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. BioMerieux SA
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Danaher Corporation
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Eppendorf
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

Key Players
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche, Ltd.
  • Abbott Laboratories
  • Agilent Technologies
  • Analytik Jena AG
  • Becton Dickson and Company
  • BioMerieux SA
  • Danaher Corporation
  • Eppendorf
Market Segmentation 

By Technology 

    • Quantitative
    • Digital

By Product 

    • Consumables & Reagents
    • Instruments
    • Software & Services

By Application 

    • Clinical
    • Research
    • Forensic and Others

By Region:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The global Compartment Syndrome Monitoring Devices Market was…
Spinal muscular atrophy (SMA) is a rare, genetic…
Myocarditis is an inflammation of the heart muscle,…
Pulmonary Arterial Hypertension (PAH) is a rare, progressive…
Uterine fibroids are a common type of noncancerous…
Lassa fever is an acute viral hemorrhagic illness…
Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect…
Single-cell Omics technology is a rapidly developing field…
Neuroplasticity is the brain's ability to reorganize itself…
A circulating tumor cell (CTC) is a cancer…